Background: Ambulatory hemodynamic monitoring with an implantable pulmonary artery (PA) sensor is approved for patients with New York Heart Association Class III heart failure (HF) and a prior HF hospitalization (HFH) within 12 months. The objective of this study was to assess the efficacy and safet...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!